And pharmaceuticals seem to be in that same situation. And I'm encouraged to hear about this investment. And I wonder if you could talk a little bit more about that. I mean, we are. President Trump has made it a priority to reshore all pharmaceutical production for critical medicines in this country. The APIs, as you know, are the precursor chemicals and compounds that go into building a variety of pharmaceutical drugs. During COVID it was became clear that we did not have any control. (00:43–00:52)
CLAIM
Asserts that President Trump prioritized reshoring pharmaceutical production for critical medicines.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
